OraSure Technologies, Inc. (OSUR)
Nasdaq: OSUR · Surgical & Medical Instruments & Apparatus · Bethlehem, PA · filing with the SEC since 2000
Grade4.2
◀ Past 4.2● Present 4.6▶ Future 3.5
Who owns OraSure Technologies, Inc.
As filed with the SECHolders of 5% or more
7
Blackrock, Inc. holds 7.2% of Common Stock, as its SCHEDULE 13G/A filed Apr 23, 2025 says.
Directors and officers
9
report now, of 33 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 23, 2025 · Common Stock
Neil Gagnon
SCHEDULE 13G · filed Aug 12, 2026 · Common Stock · 5.4% in Apr 8, 2026
YA II PN, Ltd.
SCHEDULE 13D · filed Sep 17, 2026 · Common Stock, $0.000001 par value per share
Neuberger Berman Group LLC
SCHEDULE 13G · filed Apr 4, 2025 · Common Stock · 4.9% in Jan 7, 2025
Private Management Group Inc
SCHEDULE 13G/A · filed Jul 31, 2026 · Common Stock · 7.3% in Jul 30, 2025
Altai Capital Management, L.P.
SCHEDULE 13D/A · filed Apr 20, 2026 · Common Stock, par value $0.000001 per share · 5.2% in Mar 17, 2026
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Dimensional Fund Advisors LP
SCHEDULE 13G/A · filed Oct 9, 2025 · Common Stock · reported falling below 5%
Camber Capital Management LP
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.000001 par value · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
Earnest Partners LLC
SCHEDULE 13G/A · filed Sep 3, 2025 · Common Stock · reported falling below 5%
What OSUR reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
BioMedomics, Inc
A company bought · acquisition · Oct 2025 · owns, named in the 10-K filed Mar 9, 2026
Sherlock Biosciences
A company bought · acquisition · owns, named in the 10-K filed Mar 9, 2026
4 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 9, 2026.
Insider tradesForm 4
0sales
8purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$600,000bought, in dollars
Open-market trades on Form 4 from Oct 1, 2025 to Oct 1, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 1, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 33 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Boyd Steven Kyle | director | 0 | $0 | 0 | 3 | $200,000 |
| Eglinton Manner Carrie | President & CEO | 0 | $0 | 0 | 2 | $200,000 |
| Mcgrath Kenneth J | Chief Financial Officer | 0 | $0 | 0 | 2 | $200,000 |
| Gagliano Nancy J | Director | 0 | $0 | 0 | 1 | $0 |